About Us

TheraBiome's GEMICEL oral drug delivery technology Enabling platform to specific sites in the GI-tract Proximal colon. Local and systemic.

Medical solutions. Customized delivery small intestine and colon. Proprietary delivery technology clinically validated. TheraBiome GEMICEL

Mohan Kabadi Partner Michael Atkin Partnership Advisor Jerome Schentag Amit Jolly TheraBiome GEMICEL Assembly

TheraBiome founded. Assembly Biosciences license. Human scintigraphy. Allergan. Microbiome GI products. FDA IND. UC. 1b. Abbvie. IP rights.

TheraBiome Partnering Goals based on strong science and proprietary data

Global or regional licensing rights available for GEMICEL®
Open to co-development, acquisition, or other opportunities
Ready to provide consulting support for drug product and technology transfer

Please contact us to arrange an introductory meeting.

© Copyright 2025. All rights reserved.